Bank of America’s Anavex Life Sciences AVXL Stock Holding History

Bank of America’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-249,900	Closed	-$2.3M	–	8309
2025 Q2	$2.3M	Buy	249,900 +194,000	+347%	+$1.66M	﹤0.01%	4650
2025 Q1	$480K	Buy	+55,900	New	+$528K	﹤0.01%	5669
2024 Q3	–	Sell	-175,900	Closed	-$742K	–	8166
2024 Q2	$742K	Sell	175,900 -388,800	-69%	-$1.57M	﹤0.01%	5089
2024 Q1	$2.87M	Buy	+564,700	New	+$3.18M	﹤0.01%	4145
2023 Q2	–	Sell	-101,200	Closed	-$867K	–	7703
2023 Q1	$867K	Hold	101,200	–	–	﹤0.01%	4993
2022 Q4	$937K	Buy	+101,200	New	+$1.08M	﹤0.01%	4901
2021 Q4	–	Sell	-1,000	Closed	-$18K	–	8204
2021 Q3	$18K	Buy	+1,000	New	+$19.9K	﹤0.01%	7416
2016 Q3	–	Sell	-50,000	Closed	-$306K	–	7097
2016 Q2	$306K	Buy	+50,000	New	+$242K	﹤0.01%	4984

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of America's AVXL Position: Q1 2026 in Review

Bank of America increased its Anavex Life Sciences (AVXL) stake by 65% in Q1 2026, buying an estimated $1.47M and bringing the position to 863,150 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3922.

Bank of America first reported a position in AVXL in Q4 2015 and has held it in 41 quarters since. The position peaked at $7.17M in Q1 2023. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

Bank of America held 863,150 shares of Anavex Life Sciences worth $2.65M as of Q1 2026.
Bank of America bought 338,961 Anavex Life Sciences shares in Q1 2026, an estimated $1.47M.
Anavex Life Sciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3922 holding.
Bank of America first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 41 quarters since.
Bank of America's Anavex Life Sciences position peaked at $7.17M in Q1 2023.
190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.